A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis
Clinical trial NCT03759041 · TERMINATED
Trial details
- NCT number
- NCT03759041
- Sponsor
- Seres Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-19
- Primary completion
- 2021-05-28
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.